
Does the use of Rabopep-L lead to increased risk of fractures?
Nov 4, 2023
Does the use of Rabopep-L lead to increased risk of fractures?
Multiple studies conducted on adult individuals have indicated a potential link between the use of RabopepL and a higher likelihood of experiencing osteoporosisrelated fractures in regions such as the hip wrist or spine This elevated risk of fractures was noted specifically in patients who were administered high doses of the medication It is important to note that high dose refers to the implementation of multiple daily doses and the continuation of the treatment for an extended period typically lasting a year or longer These findings emphasize the need for caution when prescribing and using RabopepL particularly in individuals who may already be at an increased risk of osteoporosisrelated fractures Healthcare professionals should carefully consider the potential benefits and risks associated with this medication and ensure that patients are closely monitored throughout the course of treatment By staying vigilant and informed both medical practitioners and patients can make wellinformed decisions regarding the usage of RabopepL and mitigate the potential risks of osteoporosisrelated fractures
Medicines
For information purposes only. Consult a doctor before taking any medicines.
₹268₹297
₹140₹156
₹125₹139
₹158₹175
₹135₹150
₹135₹150
₹149₹165
₹176₹195
₹149₹165